SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-21-000074
Filing Date
2021-05-11
Accepted
2021-05-11 06:28:32
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-5x051121.htm 6-K 27943
  Complete submission text file 0001395064-21-000074.txt   28900
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 21909536
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences